|
|
Article: SPIRIVA SIGNIFICANTLY IMPROVES LUNG FUNCTION IN PATIENTS WITH MILD COPD.
- Article from:
- AsiaPulse News
- Article date:
- September 6, 2006
CopyrightCOPYRIGHT 2006 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(Full text of statement. Contact details below.)
MUNICH, Sept. 5 /PRNewswire-AsiaNet/ --
For Non-US Media Only
- First Prospective Study to Investigate the Effect of SPIRIVA(R) in Early Stage COPD, an Under-Diagnosed Condition Affecting Overall one in ten Adults Globally
Patients with mild(x) chronic obstructive pulmonary disease (COPD) treated with SPIRIVA(R) (tiotropium) experienced significantly improved lung function compared with patients receiving placebo, according to the results of a study presented today at the annual meeting of the European Respiratory Society (ERS) congress.(1) This is the first prospective study to focus ...